Claro Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
2,546
-392
| -13% | -$175K | 0.19% | 104 |
|
|
2025
Q1 | $1.42M | Sell |
2,938
-137
| -4% | -$66.4K | 0.19% | 97 |
|
|
2024
Q4 | $1.24M | Buy |
3,075
+650
| +27% | +$262K | 0.17% | 110 |
|
|
2024
Q3 | $1.13M | Buy |
2,425
+471
| +24% | +$219K | 0.15% | 134 |
|
|
2024
Q2 | $916K | Buy |
1,954
+591
| +43% | +$277K | 0.14% | 141 |
|
|
2024
Q1 | $570K | Buy |
1,363
+98
| +8% | +$41K | 0.1% | 214 |
|
|
2023
Q4 | $515K | Buy |
1,265
+56
| +5% | +$22.8K | 0.11% | 209 |
|
|
2023
Q3 | $420K | Buy |
1,209
+143
| +13% | +$49.7K | 0.11% | 221 |
|
|
2023
Q2 | $375K | Buy |
+1,066
| New | +$375K | 0.09% | 235 |
|
|
2019
Q1 | – | Sell |
-343
| Closed | -$66K | – | 904 |
|
|
2018
Q4 | $66K | Buy |
+343
| New | +$66K | 0.05% | 296 |
|